GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Landfar Bio-medicine Co Ltd (SZSE:000504) » Definitions » Valuation Rank

Landfar Bio-medicine Co (SZSE:000504) Valuation Rank


View and export this data going back to 1992. Start your Free Trial

What is Landfar Bio-medicine Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Landfar Bio-medicine Co Valuation Rank Related Terms

Thank you for viewing the detailed overview of Landfar Bio-medicine Co's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Landfar Bio-medicine Co (SZSE:000504) Business Description

Traded in Other Exchanges
N/A
Address
13th Floor, South West, Tianxin 3 Choi Building, Changsha, CHN, 410015
NanHua Bio-medicine Co Ltd is engaged in stem cells, immune cells and tissue engineering industry.
Executives
Zhao Ze Ming Director
Liu Yi Executives
Xu Guang Mao Supervisors